Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37604,1540,1.07 [0.97-1.18],0.198547903945206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37008,361,1.21 [1.01-1.44],0.0393947470337501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,41006,281,1.02 [0.81-1.28],0.8842570100406342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28346,1283,1.18 [1.06-1.31],0.002245618844658
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,40913,188,0.99 [0.74-1.32],0.9476482210442904
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38365,144,1.28 [0.97-1.68],0.0781952542662854
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",42956,186,1.00 [0.76-1.34],0.9774459114860164
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42962,125,0.89 [0.61-1.28],0.5261175714130789
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37483,99,1.54 [1.17-2.02],0.0020355345629532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,41639,202,1.22 [0.96-1.55],0.1089361726305245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,41566,129,1.34 [1.01-1.77],0.0403214888724697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43090,117,1.05 [0.74-1.49],0.7795377252211053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43091,147,1.06 [0.78-1.45],0.694257385429644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43080,136,1.12 [0.82-1.53],0.4837676939014315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,42529,93,0.83 [0.54-1.30],0.4206420894123445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41092,698,1.15 [1.00-1.32],0.0459153782389134
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,40634,240,1.17 [0.93-1.47],0.1794452825003452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,40873,479,1.15 [0.97-1.35],0.0996584046404271
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34597,104,1.33 [0.98-1.80],0.0667630368148774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34583,90,1.17 [0.81-1.70],0.4018376775465067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",34935,442,0.91 [0.75-1.11],0.3638806247618169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",34948,455,0.91 [0.76-1.11],0.3615128193002138
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19595,564,1.08 [0.92-1.27],0.3202192467720416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15653,191,0.99 [0.75-1.32],0.9661818543125186
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34580,87,1.16 [0.79-1.70],0.4553673212830746
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38599,1315,1.20 [1.08-1.32],0.0003709108162398
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",40956,560,1.21 [1.05-1.41],0.0092844356879218
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42300,200,1.25 [0.99-1.58],0.0586989175504341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43233,190,1.21 [0.95-1.55],0.1265420850382882
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,42767,118,1.07 [0.76-1.51],0.6930453463643694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43234,116,1.22 [0.89-1.67],0.216473946287657
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Stomach,43318,85,1.14 [0.78-1.68],0.5016580056853536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,42856,493,1.05 [0.88-1.25],0.5890707571690167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43242,191,1.00 [0.76-1.33],0.98474602433141
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43249,149,1.23 [0.93-1.62],0.1529517940881867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43150,91,1.25 [0.88-1.77],0.2057252807189914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",43155,90,1.25 [0.88-1.77],0.2179598998965239
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,43004,329,0.93 [0.75-1.17],0.5370682104619827
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43267,143,0.94 [0.67-1.32],0.7165927777459502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,43081,303,0.82 [0.64-1.04],0.1039182452396102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of breast,23369,120,1.24 [0.91-1.68],0.1740679677329896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,22955,851,1.00 [0.87-1.15],0.9751902659424044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41212,327,1.34 [1.12-1.60],0.001450296723169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,40668,574,1.24 [1.07-1.43],0.0032478227861695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,40668,574,1.24 [1.07-1.43],0.0032478227861695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37545,746,0.95 [0.82-1.10],0.4837489715299261
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42388,123,1.15 [0.83-1.59],0.3928367540408378
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,42825,130,0.95 [0.67-1.34],0.7551693324022818
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35051,1908,1.16 [1.07-1.27],0.0006207421245144
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,40825,902,1.02 [0.90-1.16],0.7295558995738424
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39408,198,0.94 [0.70-1.25],0.6563200785866703
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41327,189,0.95 [0.71-1.27],0.7070149449353884
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39388,178,1.03 [0.77-1.37],0.8347399805548311
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40112,902,1.00 [0.88-1.15],0.9748511236146908
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40086,876,1.00 [0.88-1.15],0.9702152157418442
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40121,297,1.04 [0.82-1.33],0.7379540889758269
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40123,293,1.05 [0.83-1.34],0.6739600606877455
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,34763,1620,1.14 [1.04-1.25],0.006713113073698
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33354,211,1.18 [0.93-1.50],0.1806423975971527
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,34642,1499,1.13 [1.02-1.25],0.0153426718819977
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33228,85,1.48 [1.09-2.01],0.0121089519156409
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33275,132,1.43 [1.11-1.85],0.0065200712144949
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,36677,1096,0.94 [0.83-1.07],0.3510070552703229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",35984,403,0.90 [0.72-1.11],0.3154590370112924
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",42645,295,0.92 [0.72-1.18],0.515494557680982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",42747,215,0.89 [0.67-1.20],0.4508365194488362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40318,103,0.92 [0.61-1.38],0.6778154258017094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43157,103,0.92 [0.61-1.38],0.6927059624199703
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",35684,103,0.93 [0.61-1.39],0.7107383192221859
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Alcohol dependence,40339,124,0.82 [0.56-1.22],0.330724758440561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,40244,108,0.94 [0.63-1.40],0.7647846632842973
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35677,96,0.87 [0.56-1.34],0.5191444731004968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36108,527,0.96 [0.80-1.14],0.6131475395907576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression,40624,463,1.01 [0.84-1.21],0.9511589815849704
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,35712,404,0.94 [0.77-1.15],0.5597219988604849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",35797,216,0.97 [0.75-1.27],0.8470341115373046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Other anxiety disorders,40859,111,0.76 [0.50-1.15],0.1981036098748121
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,37274,2503,1.04 [0.96-1.13],0.2833879137739047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,33855,242,1.29 [1.05-1.59],0.0161477839807732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43064,193,1.35 [1.08-1.68],0.0087400399310785
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41121,807,1.08 [0.94-1.23],0.2646567531061168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,40566,252,1.15 [0.91-1.44],0.2425714505415318
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,40448,134,1.13 [0.83-1.55],0.4321177267286981
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",42811,120,1.15 [0.83-1.59],0.4045184665234118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,41936,132,1.22 [0.91-1.64],0.1841831255989584
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,40593,279,0.91 [0.71-1.16],0.4431388357258244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,42373,214,0.97 [0.74-1.27],0.8338507987545035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41347,1120,1.03 [0.92-1.16],0.5958897612068402
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40434,207,1.17 [0.91-1.50],0.2113108764047213
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,40868,641,0.98 [0.84-1.15],0.8272738694992396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,42831,139,0.67 [0.45-0.99],0.0431154901909251
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,42789,97,0.68 [0.43-1.09],0.1085492026318965
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,42493,201,0.78 [0.57-1.06],0.1162272086051041
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42207,625,0.95 [0.81-1.12],0.558101316574837
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,41939,357,0.90 [0.72-1.12],0.3479172812914742
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41711,129,0.87 [0.60-1.26],0.4656947131641281
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41780,198,0.86 [0.64-1.16],0.3313987986185871
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41710,128,1.12 [0.81-1.54],0.4965300960872306
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37316,258,1.06 [0.83-1.34],0.6550721912702934
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,37720,662,1.05 [0.90-1.22],0.5234469924869822
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,41620,343,1.10 [0.90-1.34],0.3687881407863242
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,42751,70,1.13 [0.74-1.73],0.5729085173360087
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3661,70,1.21 [0.79-1.86],0.3801113582364467
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39160,70,1.12 [0.73-1.71],0.6115983093730524
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42167,156,0.95 [0.69-1.31],0.7737788908084263
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42092,81,0.76 [0.46-1.24],0.2662677490146133
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42141,136,0.77 [0.53-1.13],0.1786789190464589
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42402,170,0.77 [0.55-1.07],0.1217314478337808
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43129,219,1.13 [0.89-1.44],0.3213788559459569
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,41888,182,0.96 [0.71-1.29],0.767878304456726
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30614,5403,1.01 [0.94-1.08],0.8174204048125531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42276,117,1.25 [0.92-1.70],0.1446148156021299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",32284,3719,1.02 [0.95-1.10],0.5670660267061156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,32323,3758,1.02 [0.95-1.10],0.5746362268315717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28658,93,1.52 [1.13-2.04],0.0059186870952366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",39638,1953,1.06 [0.97-1.16],0.2124985624985027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,38848,1163,1.06 [0.95-1.19],0.2863792188450517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41567,390,1.00 [0.82-1.22],0.9771579536550752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,41955,778,1.04 [0.90-1.19],0.6221567007749256
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43085,163,1.04 [0.78-1.41],0.7721063714619767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38173,488,1.12 [0.94-1.33],0.2131799128674024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39191,1538,1.04 [0.94-1.16],0.4088390655302437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,41921,187,1.20 [0.93-1.54],0.161890865279654
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42120,388,1.03 [0.85-1.25],0.7950333938355001
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,41899,165,0.80 [0.58-1.13],0.2044486725336805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,41900,166,0.81 [0.58-1.13],0.2130453829061525
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28724,159,0.80 [0.57-1.13],0.2103169352745054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36045,100,0.97 [0.65-1.44],0.8718891433229912
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,36146,201,1.36 [1.09-1.70],0.0058213873591816
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,23961,198,0.92 [0.68-1.25],0.596590959464929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24496,733,1.06 [0.91-1.24],0.428606835147569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,36058,113,1.15 [0.82-1.61],0.413216373151651
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36102,157,1.09 [0.81-1.46],0.5874557882388853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",41558,354,1.06 [0.87-1.30],0.5413592768712809
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",41805,255,0.72 [0.54-0.95],0.0208313094663172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",41862,216,0.73 [0.53-0.98],0.0383841203172505
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",41993,189,0.79 [0.57-1.08],0.1364345429422035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41315,126,1.29 [0.97-1.73],0.0848744110927796
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41410,221,1.05 [0.81-1.35],0.7282837179627059
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),40846,236,0.98 [0.76-1.27],0.9032574879772132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,40807,197,0.85 [0.63-1.15],0.2906540991994226
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",42938,189,0.86 [0.63-1.16],0.3164424693755577
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,41424,814,1.19 [1.05-1.35],0.0051536674376506
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,41370,136,1.18 [0.88-1.60],0.2684968161939874
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34590,3495,1.03 [0.96-1.10],0.4437473885914929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,42990,184,1.02 [0.77-1.36],0.8844133448117615
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,40250,382,1.12 [0.93-1.35],0.2185737825623293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40197,329,1.06 [0.86-1.31],0.5654889424178102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,41751,436,1.10 [0.92-1.31],0.2966781719406713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,41745,430,1.12 [0.94-1.33],0.217731790381319
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,41926,1036,0.90 [0.79-1.02],0.1097068754083261
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,41054,164,1.16 [0.88-1.53],0.299071023168149
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,41102,212,1.04 [0.80-1.35],0.7781366455894032
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41545,655,0.86 [0.73-1.02],0.0786895465892369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,41197,307,0.99 [0.79-1.24],0.9531904339952202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,19939,102,0.62 [0.39-0.99],0.0466785223039893
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,38652,1711,1.10 [1.00-1.21],0.0399145475333633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,41337,291,1.05 [0.84-1.31],0.6719349138023699
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41379,333,1.00 [0.81-1.24],0.9921157781929546
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41379,333,1.00 [0.81-1.24],0.9921157781929546
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40351,1404,1.13 [1.02-1.25],0.0143725678185522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,30930,1404,1.12 [1.02-1.24],0.0221635292899702
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30487,1404,1.13 [1.02-1.25],0.0189772479453028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",30908,1382,1.13 [1.02-1.25],0.0171401015920978
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,42675,167,1.10 [0.83-1.47],0.4918181417733145
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,40747,129,0.95 [0.67-1.34],0.7581360808034268
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",42804,129,0.94 [0.66-1.35],0.752943220777998
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,40736,118,1.04 [0.74-1.48],0.811342142518438
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,39816,182,1.11 [0.84-1.45],0.4617024394256676
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,40038,404,1.04 [0.86-1.26],0.6939567515192673
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41175,189,0.95 [0.71-1.27],0.7079922803933825
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29521,9775,1.07 [1.01-1.12],0.0113693361618439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42428,716,1.10 [0.96-1.26],0.1890946113658567
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43260,148,1.07 [0.79-1.46],0.6679899455186957
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,43266,137,1.09 [0.79-1.49],0.6152134425473332
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,41901,189,1.09 [0.83-1.43],0.5534275958396824
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41884,172,1.14 [0.87-1.50],0.3424095636545888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43246,166,1.10 [0.83-1.47],0.5062928227643831
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41873,161,0.93 [0.67-1.28],0.6402375086819908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41432,137,0.87 [0.61-1.24],0.432364852865461
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43120,94,0.90 [0.59-1.37],0.6164391979081849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33003,457,1.17 [1.00-1.38],0.0564636335615445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36186,3640,1.03 [0.96-1.10],0.3978903523862592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,33121,575,1.05 [0.90-1.23],0.5496562954488295
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,33729,1183,1.05 [0.94-1.18],0.3667941384609068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,32677,131,1.10 [0.80-1.51],0.5679331323787999
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32901,355,0.99 [0.80-1.21],0.8932244734892665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32644,98,0.74 [0.47-1.16],0.1919415488931214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,32798,252,1.25 [1.02-1.54],0.0318962910898387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,32761,215,1.22 [0.97-1.54],0.0916092037542123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43088,153,1.28 [0.98-1.67],0.0731723881326709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,32761,215,0.94 [0.71-1.24],0.6503859798843434
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),33909,1363,1.01 [0.91-1.13],0.8080474720630857
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,43047,216,1.01 [0.78-1.32],0.933566486193092
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,33277,731,1.10 [0.95-1.26],0.194559086815475
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,32828,282,0.83 [0.65-1.07],0.1520663614193767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43026,271,1.02 [0.81-1.30],0.8414316328685686
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,43005,174,1.08 [0.82-1.43],0.5842060363786745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,37966,2728,1.05 [0.97-1.13],0.2482437800675524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,36245,1007,0.97 [0.86-1.11],0.686879303659617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,35444,206,1.19 [0.94-1.52],0.1552836031994396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,35404,166,1.19 [0.91-1.56],0.1946540094434858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,36690,1452,1.04 [0.94-1.15],0.4424551948402626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,41670,1290,1.10 [0.99-1.22],0.0663919713859621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,33965,3362,1.11 [1.03-1.18],0.0043790306736468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42746,102,1.11 [0.77-1.59],0.5811078726102125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43203,139,1.08 [0.79-1.48],0.6285873247569806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,40519,139,1.09 [0.79-1.49],0.6092529287992063
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40485,105,1.25 [0.90-1.74],0.1824395323333401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43081,233,1.06 [0.83-1.35],0.6582080087655549
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,40613,233,1.06 [0.83-1.36],0.6227323910962221
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40587,207,1.04 [0.80-1.36],0.7709352345739714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41430,1050,1.11 [0.99-1.25],0.0711005550593714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41419,1039,1.11 [0.99-1.25],0.0761531911927891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,30770,167,1.31 [1.01-1.69],0.0403877559139152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal stricture,42540,167,1.27 [0.99-1.64],0.0599684838473683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",30717,114,1.30 [0.95-1.77],0.1001629530453812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31600,997,1.04 [0.91-1.18],0.5784918287676843
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,30879,276,0.96 [0.76-1.23],0.7579318863965051
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31084,481,1.14 [0.96-1.35],0.1355262123501419
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,40613,433,1.14 [0.96-1.36],0.1404591842264093
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,42555,151,1.28 [0.98-1.66],0.0720791426121157
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30852,249,0.99 [0.77-1.27],0.9311433437105155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30729,126,1.28 [0.95-1.73],0.1041249240692707
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32083,1480,1.10 [0.99-1.21],0.0738947545747666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,31057,454,1.20 [1.01-1.41],0.0376306168026529
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42533,129,1.18 [0.87-1.60],0.2813062719391062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,41942,205,1.24 [0.98-1.57],0.0720745171484658
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,41848,111,1.25 [0.91-1.71],0.1614971484281392
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",40990,1028,0.96 [0.85-1.09],0.5065801884570919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,40785,823,1.01 [0.88-1.15],0.8996472701413869
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,40121,159,0.74 [0.52-1.06],0.0986140612810587
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40038,76,1.11 [0.73-1.68],0.6326897010448795
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,40072,110,1.11 [0.78-1.57],0.5685841339138724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),43008,110,1.11 [0.78-1.57],0.5671427033671952
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,40987,528,1.23 [1.06-1.42],0.0069870426310727
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40578,119,1.35 [1.02-1.79],0.0385105942425028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,40558,99,1.36 [1.00-1.85],0.0509011643780091
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40542,83,1.44 [1.05-1.98],0.0227836968439883
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,40796,337,1.11 [0.91-1.35],0.3231125718974937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,40784,325,1.11 [0.90-1.36],0.3302581364476652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38048,2646,1.10 [1.02-1.19],0.0115513456078651
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,42552,183,0.90 [0.67-1.22],0.5144069738156853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42612,782,1.07 [0.93-1.22],0.3594399768628887
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,40677,977,1.06 [0.94-1.19],0.3704906921123293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,41766,681,1.26 [1.11-1.44],0.0004775691229247
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41240,155,1.44 [1.13-1.83],0.003456689553804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41517,432,1.26 [1.08-1.48],0.0042209137196639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,42831,152,1.05 [0.77-1.42],0.7719391534142104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,42796,117,1.05 [0.74-1.49],0.7925015092754921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42770,91,1.06 [0.72-1.57],0.7680949226346137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41932,102,0.93 [0.63-1.39],0.7341192749880195
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42450,620,1.07 [0.92-1.25],0.3612503038430087
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,39853,153,1.09 [0.81-1.47],0.5597259103580883
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39871,171,1.23 [0.96-1.59],0.1071329612341455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39832,132,1.17 [0.87-1.59],0.3044830172262498
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40075,375,0.88 [0.71-1.10],0.257161031586632
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40039,339,0.86 [0.68-1.08],0.1995295005773152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31202,6712,1.02 [0.96-1.08],0.504531453146364
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,33918,3912,1.03 [0.97-1.10],0.3571979563607601
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,39047,2042,0.97 [0.88-1.06],0.4496935508807119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30264,258,1.26 [1.03-1.55],0.0240823907046868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,30785,779,1.19 [1.05-1.35],0.0058845937742976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",42590,247,1.28 [1.04-1.57],0.0206004030451235
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,42606,223,1.30 [1.04-1.61],0.0187440848262315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,31928,1922,1.02 [0.93-1.11],0.7222546566136627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36278,1922,1.01 [0.92-1.11],0.7951556193033917
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30126,120,1.25 [0.92-1.70],0.1519715447834342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42379,116,1.27 [0.93-1.73],0.1351520114679157
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30367,361,1.18 [0.99-1.41],0.0662641124838114
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30125,119,0.66 [0.44-1.00],0.052792852499143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30480,474,0.89 [0.74-1.08],0.2443564087621181
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43027,240,0.86 [0.65-1.12],0.2611586663195605
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,30888,882,1.03 [0.90-1.17],0.6550636211214793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30659,653,1.14 [0.99-1.31],0.0724929814502058
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32188,2182,0.97 [0.89-1.06],0.5219556208633257
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30122,116,1.07 [0.76-1.50],0.6922269306209179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30397,391,0.95 [0.78-1.16],0.6245298693115955
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30095,89,0.90 [0.58-1.38],0.6155829170366554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30106,100,0.87 [0.58-1.31],0.4966339821621351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,30821,815,1.00 [0.87-1.15],0.9774836528403292
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,30708,702,1.03 [0.89-1.19],0.7259329525304135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33534,478,0.95 [0.79-1.14],0.5991219641345886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42350,241,1.08 [0.84-1.37],0.556756841898827
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42206,97,1.22 [0.86-1.72],0.2644853424640007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37496,105,0.93 [0.63-1.38],0.7176455948143773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,37898,507,0.94 [0.78-1.12],0.4727230118856564
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,38957,1566,0.96 [0.87-1.07],0.4500029252237822
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,37711,320,0.96 [0.77-1.20],0.7490585333657269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37534,143,0.78 [0.54-1.12],0.1822311338672227
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",38630,1239,0.97 [0.86-1.08],0.5662887030236552
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37480,89,1.10 [0.75-1.61],0.6427246639219053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,37788,397,1.06 [0.88-1.28],0.5326265897351705
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37561,170,1.15 [0.87-1.51],0.3290366533419208
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37523,132,0.95 [0.67-1.34],0.7740280069511751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37618,227,1.04 [0.80-1.34],0.7828052879470858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37499,108,1.10 [0.77-1.57],0.5927098839222491
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,37910,519,0.97 [0.81-1.15],0.7177203118205387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37524,519,0.93 [0.77-1.11],0.4060643328631317
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37116,111,0.53 [0.34-0.84],0.0065789820346052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37152,147,0.96 [0.69-1.34],0.809841292612123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37174,169,1.32 [1.03-1.69],0.0303730850148203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37092,87,1.20 [0.83-1.75],0.3365745765874752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37201,196,1.09 [0.84-1.43],0.5140305754659351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37180,175,1.13 [0.86-1.49],0.3867753220514642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37441,436,1.01 [0.83-1.22],0.9461851160662804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37100,95,1.10 [0.75-1.62],0.6133759628916834
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37133,128,0.83 [0.57-1.21],0.3259506587365454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37215,210,0.94 [0.71-1.24],0.6586359851595835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37114,109,0.96 [0.65-1.40],0.8174293597649148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",37766,761,0.90 [0.78-1.05],0.18133893218908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37295,290,0.93 [0.73-1.18],0.568034168003535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37421,416,0.92 [0.76-1.13],0.4362441918217516
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40138,295,1.11 [0.90-1.37],0.3264296366246086
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40492,649,1.07 [0.92-1.24],0.391307600912937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,39920,77,0.81 [0.50-1.32],0.4041461855858572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,39936,93,1.23 [0.86-1.74],0.2551960985206496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40008,165,1.19 [0.91-1.56],0.210804413031486
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34532,7115,1.08 [1.02-1.13],0.0048427478326514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17149,1047,1.12 [0.99-1.26],0.0769216653066545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39145,365,1.31 [1.11-1.55],0.0017716492352636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,38886,106,1.11 [0.78-1.58],0.557838954353309
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,39371,78,1.26 [0.87-1.82],0.229994545370623
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39375,82,1.98 [1.58-2.48],3.312320584735526e-09
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39388,95,1.65 [1.27-2.14],0.0001494232112488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42685,393,0.96 [0.78-1.17],0.6731019685934032
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,42599,112,1.16 [0.83-1.62],0.3890336666207967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42575,283,0.85 [0.66-1.09],0.2089072699069467
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42432,140,1.13 [0.83-1.54],0.44738156801098
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,39631,1752,1.07 [0.98-1.17],0.1435683845148131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,38029,150,1.06 [0.78-1.44],0.6959227514811781
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38012,133,0.99 [0.71-1.39],0.9701638018369294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38328,449,1.21 [1.03-1.42],0.0218851963033751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38068,189,1.19 [0.93-1.53],0.1730880465875622
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39036,1157,1.04 [0.93-1.16],0.4954018932362161
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16573,471,1.09 [0.91-1.30],0.3660255012207646
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16187,85,1.54 [1.12-2.10],0.0071872764226526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16185,83,1.27 [0.87-1.85],0.2217300893202738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16234,132,1.00 [0.70-1.41],0.9823458881418696
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16236,134,1.24 [0.92-1.67],0.1585404288572509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16268,166,0.95 [0.69-1.30],0.73181890770796
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23169,417,1.11 [0.93-1.33],0.262018403152198
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22881,129,1.23 [0.91-1.66],0.1718178945631263
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22893,141,0.82 [0.57-1.18],0.2777772087786495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22855,103,1.05 [0.72-1.52],0.7958571783050096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23095,479,1.11 [0.94-1.32],0.2212782969366347
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22733,117,1.06 [0.75-1.50],0.7376444622311148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22827,211,1.20 [0.94-1.52],0.140546128274977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21362,3888,1.03 [0.96-1.10],0.4317029984123159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,17775,301,0.85 [0.66-1.09],0.1970111747350945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17558,84,0.96 [0.62-1.48],0.8566291113819678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17612,138,0.81 [0.56-1.18],0.2734178438801348
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18150,676,1.00 [0.86-1.16],0.9871478032593776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17812,338,0.93 [0.74-1.16],0.5038975969817496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18278,804,1.10 [0.96-1.26],0.1560147138507598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17741,267,1.12 [0.90-1.40],0.3160888862077132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17848,374,0.95 [0.77-1.17],0.6176178000089413
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17555,81,1.29 [0.92-1.82],0.139434266751461
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17640,166,1.20 [0.91-1.57],0.1935045037553677
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23388,230,1.12 [0.88-1.43],0.3686820625055589
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23397,218,1.11 [0.86-1.43],0.4179227172866645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23418,118,1.08 [0.76-1.52],0.6685497796574883
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23410,130,1.13 [0.82-1.55],0.4683102683397245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17596,122,0.82 [0.56-1.21],0.320091432158596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17573,99,1.19 [0.84-1.69],0.320632404113828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17594,120,1.07 [0.76-1.51],0.6857966835650167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23330,391,0.97 [0.79-1.18],0.7414749971555772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18612,1138,0.98 [0.87-1.11],0.7518604878758844
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18218,744,0.98 [0.84-1.14],0.7641905591672724
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23404,170,0.93 [0.68-1.27],0.635620298890005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17865,391,1.03 [0.85-1.26],0.7348452919570985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17732,258,0.82 [0.62-1.07],0.1373879039157672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18252,778,1.08 [0.94-1.24],0.2603320696288793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female infertility,17558,84,1.01 [0.66-1.55],0.954970785186674
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17551,77,0.99 [0.63-1.56],0.9744354655818196
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23415,719,0.99 [0.84-1.17],0.9237584342014612
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23422,990,1.02 [0.88-1.18],0.8132258827037442
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23415,375,1.12 [0.91-1.37],0.2759647139868945
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23145,105,0.71 [0.45-1.13],0.1470956795403419
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23192,152,1.35 [1.04-1.76],0.0235866814630366
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23173,133,1.14 [0.83-1.59],0.4182241213660798
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23431,139,0.78 [0.53-1.13],0.188094206837315
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23433,137,0.76 [0.52-1.11],0.1552498449392194
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23429,352,0.89 [0.70-1.12],0.3180391242754667
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23179,102,1.22 [0.87-1.70],0.2547010169473704
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23276,199,0.95 [0.71-1.28],0.7392861657794223
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22820,124,1.03 [0.71-1.48],0.8848355892028937
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22859,163,0.88 [0.62-1.24],0.4631565368922613
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22896,200,1.14 [0.87-1.48],0.3443607803132004
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22817,121,0.97 [0.67-1.43],0.8962623070738311
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22809,113,1.22 [0.87-1.70],0.2454143171823976
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22819,123,0.88 [0.59-1.30],0.5124106936892527
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22623,191,1.05 [0.79-1.39],0.7231241844093645
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22800,368,1.12 [0.92-1.37],0.2658379234794943
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22983,551,1.10 [0.92-1.32],0.2851542717625464
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23435,145,1.01 [0.72-1.41],0.9719957429567272
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22234,110,0.88 [0.58-1.34],0.5528991523126033
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22517,85,1.04 [0.67-1.60],0.8727753250175763
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23440,280,1.07 [0.84-1.36],0.5930915411989914
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23379,219,1.01 [0.76-1.33],0.9596274284686942
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23429,203,1.12 [0.86-1.46],0.4013025959713854
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23420,194,1.13 [0.86-1.49],0.3674112691030049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",42668,102,0.98 [0.66-1.44],0.9026026399744734
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,39120,998,0.94 [0.82-1.07],0.3190732134342668
